Categories AlphaGraphs, Earnings, Health Care

Biogen posts Q3 earnings well above estimates

Biogen (NASDAQ: BIIB) reported third-quarter 2021 financial results before the regular market hours on Wednesday. The company reported Q3 revenue of $2.78 billion, down 18% year-over-year and higher than the Wall Street projection. Net income of $4.77 per share was also well above the target that analysts had anticipated.

BIIB shares rose 2% immediately following the announcement. The stock has gained a modest 10% since the beginning of this year.

Biogen Q3 2021 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Biogen Q3 earnings call transcript

Prior performance

  • Biogen Q3 2020 earnings.

Most Popular

Shopify (SHOP): This recession-proof stock looks unstoppable. Here’s why

The virus-related movement restrictions have had a complementary effect on the business of Shopify Inc. (NYSE: SHOP), which was already thriving on the widespread cloud adoption and digital shift. The

IPO: Here are the things to know about Fresh Grapes’ market debut

There has been a spurt in the number of food and beverages companies going public lately, but many of them failed to perform as expected in the stock market. Fresh

Hormel Foods (HRL) fine-tunes biz strategy to beat challenges. Is the stock a buy?

For consumer staples companies, rising inflation is probably turning into a bigger challenge than the virus-induced supply chain disruption and store closures. After bettering its position since the early months

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top